Evidence map›Paper›PMID 41350354›Full record

ArticleScientific reports2025

Non-small cell lung cancer subtype classification based on cross-scale multi-instance learning.

Peihe Jiang, Weilong Chen, Guibin Zheng, Xinna Li, Xiaogang Song

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Peihe JiangSchool of Physics and Electronic Information, Yantai University, Yantai, 264005, China.
Weilong ChenSchool of Physics and Electronic Information, Yantai University, Yantai, 264005, China.
Guibin ZhengDepartment of Thyroid Surgery, Yantai Yuhuangding Hospital, Qingdao University, Yantai, 264000, China. 747640146@qq.com.
Xinna LiDepartment of Pathology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, 264000, China. lixinna989722@163.com.
Xiaogang SongDepartment of Pulmonary and Critical Care Medicine, Yantai Yuhuangding Hospital, Qingdao University, Yantai, 264000, China. yhdsxg@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), the two major subtypes of non-small cell lung cancer (NSCLC), present significant diagnostic challenges with direct implications for treatment planning. In this study, we propose a novel multi-instance learning (MIL) pathological image classification model that incorporates an additive attention mechanism and a new category classifier to enhance subtype discrimination. The model further integrates a cross-scale focal region detection strategy to improve sensitivity to key histological features. Trained on the Cancer Genome Atlas (TCGA) dataset, our model achieved a subtype classification accuracy (ACC) of 97.0% and an area under the ROC curve (AUC) of 0.978, outperforming state-of-the-art methods including ABMIL, CLAM, DS-MIL, DTFD-MIL, FR-MIL, and WIKG-MIL across multiple evaluation metrics. Ablation studies validate the contribution of each module to overall performance improvement. Generalization experiments conducted on the Clinical Proteomic Tumor Analysis Consortium (CPTAC) Cancer Imaging Archive (TCIA) Lung dataset and an external dataset from Yantai Yuhuangding Hospital demonstrate the robustness of our model, achieving ACCs of 91.2% and 93.0%, and AUCs of 0.967 and 0.968, respectively. These results underscore the model's strong generalization ability and its potential as a reliable tool for accurate NSCLC subtype classification across diverse clinical scenarios.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsMachine LearningAdenocarcinoma of LungHumansROC CurveMulti-instance learningMulti-scaleNon-small cell lung cancerPathology

Identifiers

PMID41350354
PMCPMC12680773

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.